Examining Critical Gaps in AF Stroke Prevention – JTH
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Alexander Benz et al, adding:
“Antithrombotic Therapy in Patients with Atrial Fibrillation: Unresolved Issues and Future Directions
This review examines critical gaps in AF stroke prevention, including limitations of current risk scores, populations where vitamin K antagonists remain preferred, uncertain net benefit in special groups, and the emerging promise of factor XI inhibitors for safer anticoagulation.”
Title: Antithrombotic therapy in patients with atrial fibrillation: unresolved issues and future directions
Authors: Alexander Benz, Stephanie Carlin, John Eikelboom
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 28, 2026, 19:04Roberta Gualtierotti: High Engagement for Research on Non-Replacement Therapies in Hemophilia
-
Mar 28, 2026, 19:02Marking a Century of Progress in von Willebrand Disease – HFA
-
Mar 28, 2026, 18:57Jim Hoffman: NETosis Dysregulation Links Cancer Progression and Autoimmunity
-
Mar 28, 2026, 18:55Ifeanyichukwu Ifechidere: Which Coagulation Factors Are Not Involved in Bleeding?
-
Mar 28, 2026, 18:52Simon Senanu: Key Laboratory Markers of Hemolytic Anemia
-
Mar 28, 2026, 18:51Asad Ikram: Headache and Visual Impairment in Idiopathic Intracranial Hypertension
-
Mar 28, 2026, 18:48Abdul Mannan: How SSRIs Might Affect Platelet Function
-
Mar 28, 2026, 18:47Cedric Hermans: A Useful Platform for Daily Practice in Hemostasis
-
Mar 28, 2026, 18:41Amy Delderfield: One Trial, Big Implications for Anticoagulant Choice